Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate

Glioblastoma (GBM) is a primary malignant brain tumor with a dismal prognosis, partially due to our inability to completely remove and kill all GBM cells. Rapid tumor recurrence contributes to a median survival of only 15 months with the current standard of care which includes maximal surgical resec...

Full description

Bibliographic Details
Main Authors: Cyntanna C. Hawkins, Tomader Ali, Sasanka Ramanadham, Anita B. Hjelmeland
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/10/1357
_version_ 1797552887631446016
author Cyntanna C. Hawkins
Tomader Ali
Sasanka Ramanadham
Anita B. Hjelmeland
author_facet Cyntanna C. Hawkins
Tomader Ali
Sasanka Ramanadham
Anita B. Hjelmeland
author_sort Cyntanna C. Hawkins
collection DOAJ
description Glioblastoma (GBM) is a primary malignant brain tumor with a dismal prognosis, partially due to our inability to completely remove and kill all GBM cells. Rapid tumor recurrence contributes to a median survival of only 15 months with the current standard of care which includes maximal surgical resection, radiation, and temozolomide (TMZ), a blood–brain barrier (BBB) penetrant chemotherapy. Radiation and TMZ cause sphingomyelinases (SMase) to hydrolyze sphingomyelins to generate ceramides, which induce apoptosis. However, cells can evade apoptosis by converting ceramides to sphingosine-1-phosphate (S1P). S1P has been implicated in a wide range of cancers including GBM. Upregulation of S1P has been linked to the proliferation and invasion of GBM and other cancers that display a propensity for brain metastasis. To mediate their biological effects, SMases and S1P modulate signaling via phospholipase C (PLC) and phospholipase D (PLD). In addition, both SMase and S1P may alter the integrity of the BBB leading to infiltration of tumor-promoting immune populations. SMase activity has been associated with tumor evasion of the immune system, while S1P creates a gradient for trafficking of innate and adaptive immune cells. This review will explore the role of sphingolipid metabolism and pharmacological interventions in GBM and metastatic brain tumors with a focus on SMase and S1P.
first_indexed 2024-03-10T16:07:26Z
format Article
id doaj.art-3a595464e71d4edbb29a930078de41ac
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T16:07:26Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-3a595464e71d4edbb29a930078de41ac2023-11-20T14:47:05ZengMDPI AGBiomolecules2218-273X2020-09-011010135710.3390/biom10101357Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-PhosphateCyntanna C. Hawkins0Tomader Ali1Sasanka Ramanadham2Anita B. Hjelmeland3Department of Cell, Developmental, and Integrative Biology, University of Birmingham at Alabama, Birmingham, AL 35233, USAResearch Department, Imperial College London Diabetes Centre, Abu Dhabi P.O. Box 48338, UAEDepartment of Cell, Developmental, and Integrative Biology, University of Birmingham at Alabama, Birmingham, AL 35233, USADepartment of Cell, Developmental, and Integrative Biology, University of Birmingham at Alabama, Birmingham, AL 35233, USAGlioblastoma (GBM) is a primary malignant brain tumor with a dismal prognosis, partially due to our inability to completely remove and kill all GBM cells. Rapid tumor recurrence contributes to a median survival of only 15 months with the current standard of care which includes maximal surgical resection, radiation, and temozolomide (TMZ), a blood–brain barrier (BBB) penetrant chemotherapy. Radiation and TMZ cause sphingomyelinases (SMase) to hydrolyze sphingomyelins to generate ceramides, which induce apoptosis. However, cells can evade apoptosis by converting ceramides to sphingosine-1-phosphate (S1P). S1P has been implicated in a wide range of cancers including GBM. Upregulation of S1P has been linked to the proliferation and invasion of GBM and other cancers that display a propensity for brain metastasis. To mediate their biological effects, SMases and S1P modulate signaling via phospholipase C (PLC) and phospholipase D (PLD). In addition, both SMase and S1P may alter the integrity of the BBB leading to infiltration of tumor-promoting immune populations. SMase activity has been associated with tumor evasion of the immune system, while S1P creates a gradient for trafficking of innate and adaptive immune cells. This review will explore the role of sphingolipid metabolism and pharmacological interventions in GBM and metastatic brain tumors with a focus on SMase and S1P.https://www.mdpi.com/2218-273X/10/10/1357glioblastomasphingolipidsphingosine-1-phosphatesphingomyelinasesphingomyelinmetastasis
spellingShingle Cyntanna C. Hawkins
Tomader Ali
Sasanka Ramanadham
Anita B. Hjelmeland
Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
Biomolecules
glioblastoma
sphingolipid
sphingosine-1-phosphate
sphingomyelinase
sphingomyelin
metastasis
title Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
title_full Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
title_fullStr Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
title_full_unstemmed Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
title_short Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
title_sort sphingolipid metabolism in glioblastoma and metastatic brain tumors a review of sphingomyelinases and sphingosine 1 phosphate
topic glioblastoma
sphingolipid
sphingosine-1-phosphate
sphingomyelinase
sphingomyelin
metastasis
url https://www.mdpi.com/2218-273X/10/10/1357
work_keys_str_mv AT cyntannachawkins sphingolipidmetabolisminglioblastomaandmetastaticbraintumorsareviewofsphingomyelinasesandsphingosine1phosphate
AT tomaderali sphingolipidmetabolisminglioblastomaandmetastaticbraintumorsareviewofsphingomyelinasesandsphingosine1phosphate
AT sasankaramanadham sphingolipidmetabolisminglioblastomaandmetastaticbraintumorsareviewofsphingomyelinasesandsphingosine1phosphate
AT anitabhjelmeland sphingolipidmetabolisminglioblastomaandmetastaticbraintumorsareviewofsphingomyelinasesandsphingosine1phosphate